Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II.
By Joshua A. Beckman, F. Paneni, F. Cosentino, M. Creager. European Heart Journal, 2013
612 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery
View Paper: https://www.semanticscholar.org/paper/c9ca2c549263be564fd934a8300d336da9517f15
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- E. Oikonomou
- G. Vogiatzi
- G. Papamikroulis
- D. Tousoulis
- S. Tsalamandris
- A. Antonopoulos
- S. Deftereos
- S. Papaioannou
Citations in the corpus
- Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes – Mechanisms, Management, and Clinical Considerations (2016, neutral): “6 years earlier,(1) with greater severity, and with more diffuse distribution than in individuals without diabetes mellitus.(2,3) Furthermore, about two-thirds of deaths in people with diabetes mellitus are attributable to cardiovascular disease: of these, ≈40% are from ischemic heart disease, 15% f”
- The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives (2018, background): “Moreover, CVD typically occurs one to two decades earlier in people with diabetes, with more aggressive, severe and diffuse distribution.(4,5) The first WHO global report on diabetes published in 2016 demonstrates that the number of adults living with diabetes has almost quadrupled since 1980 to 422”